Ventyx Biosciences Inc (NASDAQ:VTYX) shares, rose in value on Wednesday, April 16, with the stock price down by -4.50% to the previous day’s close as strong demand from buyers drove the stock to $1.06.
Actively observing the price movement in the last trading, the stock closed the session at $1.11, falling within a range of $1.02 and $1.0996. The value of beta (5-year monthly) was 0.749. Referring to stock’s 52-week performance, its high was $5.66, and the low was $0.78. On the whole, VTYX has fluctuated by -22.63% over the past month.
With the market capitalization of Ventyx Biosciences Inc currently standing at about $75.39 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VTYX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of VTYX currently trading nearly -4.02% and -22.93% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.12, while the 7-day volatility ratio is showing 11.98% which for the 30-day chart, stands at 9.98%. Furthermore, Ventyx Biosciences Inc (VTYX)’s beta value is 0.76, and its average true range (ATR) is 0.11.
A comparison of Ventyx Biosciences Inc (VTYX) with its peers suggests the former has fared considerably weaker in the market. VTYX showed an intraday change of -4.50% in last session, and over the past year, it shrunk by -77.30%%.
Data on historical trading for Ventyx Biosciences Inc (NASDAQ:VTYX) indicates that the trading volumes over the past 10 days have averaged 1.73 and over the past 3 months, they’ve averaged 1.22 million. According to company’s latest data on outstanding shares, there are 71.13 million shares outstanding.
Nearly 12.13% of Ventyx Biosciences Inc’s shares belong to company insiders and institutional investors own 76.54% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.35 million shares as on 2025-03-31, resulting in a short ratio of 9.62. According to the data, the short interest in Ventyx Biosciences Inc (VTYX) stood at 1209.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 6.67 million. The stock has fallen by -51.60% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VTYX stock heading into the next quarter.
